Maxine Gowen
Director, HUMAN GENOME SCIENCES INC.
Companies
- Merus N.V.Board member Jun 2, 2021 to now1
- Passage BIO, Inc.Board member Feb 22, 2021 to now2
- Aclaris Therapeutics, Inc.Board member Jul 3, 2019 to now3
- Idera SoftwareBoard member Jan 6, 2016 to Aug 11, 20234
- Akebia Therapeutics, Inc.Board member Aug 1, 2014 to Jun 9, 20205
- Trevena IncBoard member Jan 30, 2014 to May 15, 20206
- Trevena IncChief executive officer Jan 30, 2014 to Feb 5, 20196
- Trevena IncPresident Jan 30, 2014 to Feb 5, 20196
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aclaris Therapeutics, Inc. ACRS33,334 shares7$109.3K at $3.28Jun 5, 2026
Idera Software0 shares8Aug 10, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 5, 2026Exercised options 11,580 shares of Aclaris Therapeutics, Inc.7
- Jun 6, 2025Exercised options 4,793 shares of Aclaris Therapeutics, Inc.9
- Jun 1, 2024Exercised options 4,660 shares of Aclaris Therapeutics, Inc.10
- Aug 10, 2023Sold 51 shares at $0.51 of Idera Software8
- Jun 2, 2023Exercised options 4,507 shares of Aclaris Therapeutics, Inc.11
- Jun 3, 2022Exercised options 3,356 shares of Aclaris Therapeutics, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMerus N.V., Board member
- 2SEC EDGARPassage BIO, Inc., Board member
- 3
- 4SEC EDGARIdera Software, Board member
- 5
- 6SEC EDGARTrevena Inc, Board member
- 7
- 8
- 9SEC EDGARForm 4 filed Jun 9, 2025
- 10SEC EDGARForm 4 filed Jun 4, 2024
- 11SEC EDGARForm 4 filed Jun 5, 2023
- 12SEC EDGARForm 4 filed Jun 6, 2022